NuHealth currently utilizes two external Institutional Review Boards (IRBs) – Northwell Health (formerly NSLIJ) (the Feinstein Institute for Medical Research) and Biomedical Research Alliance of New York (BRANY) – to review all sponsored research projects and to ensure that all research involving humans conducted at NuHealth are performed in compliance with federal regulations.
NuHealth principal investigators and co-investigators cannot initiate any human subject research until they receive a written IRB approval for the study.
Regardless of the external IRB utilized, all research being sent to Northwell Health (formerly NSLIJ) IRB or BRANY IRB must be authorized by the ORSP.
Northwell Health (formerly NSLIJ) IRB
NuHealth utilizes Northwell Health (formerly NSLIJ) IRB for all sponsored research with the exception of industry-sponsored clinical trials. The industry-sponsored clinical trials are reviewed by BRANY IRB (see below). Please refer to the Feinstein Institute for Medical Research website for their submission process and forms.
Northwell Health (formerly NSLIJ) IRB Information
Office of the Human Research Protection Program
3333 New Hyde Park Road, Suite 317
New Hyde Park, NY 11042
IRB General Number: (516) 321-2100
Northwell Health (formerly NSLIJ) IRB Contact for NuHealth
Richard Ramdeo, CIP
NuHealth utilizes BRANY IRB to review all pharmaceutically sponsored clinical studies. Please refer to the BRANY website for their regulatory submission requirements as well as requirements for continuations, amendments, and Serious Adverse Event (SAE) reporting by the PI/research team.
BRANY IRB Information
Biomedical Research Alliance of New York
1981 Marcus Avenue, Suite 210
Lake Success, NY 11042
BRANY IRB Contact for NuHealth
Linda Reuter, MS, CIP